Sana Biotechnology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $294,940,000.
Profit Margin
| 2019 | 0 | -130.77M | |
|---|---|---|---|
| 2020 | 0 | -278.63M | |
| 2021 | 0 | -344.18M | |
| 2022 | 0 | -266.38M | |
| 2023 | 0 | -283.25M |
SANA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 30.86M | 27.73M | 17.91M | 10.17M | 3.92M |
Gross profit | -30.86M | -27.73M | -17.91M | -10.17M | -3.92M |
Operating exp. | |||||
Research and development | 221.64M | 201.00M | 306.49M | 257.87M | 119.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 294.94M | 272.56M | 356.90M | 286.14M | 141.15M |
Operating income | -326.9M | -272.56M | -356.90M | -286.14M | -141.15M |
Other income (expenses), net | 43.64M | 3.08M | 981K | 844K | 2.82M |
Income before tax | -283.25M | -269.47M | -355.92M | -285.30M | -138.32M |
Income tax expense | 0 | -3.08M | -11.74M | -6.66M | -7.54M |
Net income | -283.25M | -266.38M | -344.18M | -278.63M | -130.77M |
Earnings per share | |||||
Basic EPS | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 |
Diluted EPS | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 |
| Data source | Data source | Data source |